In tumor cells of the lesion, the factor XIIIa positivity confirms dermal dendrocyte differentiation, the neoplastic component central to dermatofibroma formation, while CD34 negativity excludes vascular proliferation and aids in distinguishing MEDFs from DFSP. The gene discussed is F13A1; the disease is neoplasm.